Renal impairment associated with tenofovir disoproxil fumarate for antiretroviral therapy and HIV pre-exposure prophylaxis: An observational cohort study.

Jack E HeronHamish McManusTobias VickersKathleen RyanEdwina WrightAllison CarterMark StooveJason AsselinAndrew GrulichBasil DonovanRebecca GuyRick VarmaMarcus ChenNathan RyderDavid A LewisDavid J TempletonCatherine C O'ConnorDavid M Graceynull null

Published in: PloS one (2023)

Patients prescribed TDF-based PrEP had lower rates of renal impairment than patients prescribed TDF for HIV infection. In propensity analysis, after matching for some risk factors, rates of renal impairment remained higher amongst patients with HIV.

Keyphrases

antiretroviral therapy
hiv infected
hiv positive
human immunodeficiency virus
end stage renal disease
hiv aids
risk factors
ejection fraction
newly diagnosed
hiv infected patients
chronic kidney disease
men who have sex with men
hepatitis c virus
hiv testing
south africa
patient reported outcomes
patient reported